## Gene Summary
NOTCH4 (Notch Receptor 4) is a member of the Notch family of receptors, a group of highly conserved cell surface receptors that play a pivotal role in regulating cell fate decisions. NOTCH4 is involved in the Notch signaling pathway, which influences a variety of developmental processes, including cell differentiation, proliferation, and apoptosis. It is primarily expressed in endothelial cells and plays significant roles in vascular biology and immune function. The gene encodes a single-pass transmembrane receptor that interacts with multiple glycoprotein ligands, which induce proteolytic release of the intracellular domain, triggering transcriptional activator activity in the nucleus.

## Gene Drugs, Diseases, Phenotypes, and Pathways
NOTCH4, through its involvement in the Notch signaling pathway, is implicated in several critical biological processes and pathways, including angiogenesis, immune response regulation, and cell differentiation. Abnormal function and mutations of NOTCH4 are linked to a variety of disorders but are most notably associated with susceptibility to schizophrenia and other mental health disorders. This gene's role in vascular development and pathology similarly connects it to vascular diseases and possibly to rheumatoid arthritis and other inflammatory conditions. Understanding of NOTCH4's specific disease mechanisms could yield insights into new therapeutic approaches.

## Pharmacogenetics
NOTCH4's pharmacogenetics primarily revolves around its association with neuropsychiatric disorders, especially schizophrenia. The gene is investigated for its role in the modulation of the immune system and potential impacts on the effectiveness and response rates of drugs treating schizophrenia and other psychological disorders, although specific treatments targeting NOTCH4 are still under research. The detailed mechanism whereby NOTCH4 alterations influence drug response or susceptibility to side effects remains a subject of ongoing investigation. However, due to its role in immune modulation, it could affect responses to immunotherapeutic agents and potentially some biologics used in autoimmune diseases like rheumatoid arthritis.